Skip to search formSkip to main contentSkip to account menu

clevidipine

Known as: butyroxymethyl methyl 4-(2',3'-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate 
National Institutes of Health

Related topics

Related topics

7 relations
100 ML clevidipine 0.5 MG/ML Injection [Cleviprex]Calcium Channel Antagonists [MoA]Dihydropyridines

Broader (2)

Calcium Channel BlockersPyridines

Narrower (2)

Clevidipine butyrateCleviprex

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Perioperative hypertension management
Perioperative hypertension is commonly encountered in patients that undergo surgery. While attempts have been made to standardize… 
Highly Cited
2008
Highly Cited
2008
Treatment of Acute Postoperative Hypertension in Cardiac Surgery Patients: An Efficacy Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery-2 (ESCAPE-2), a…
BACKGROUND: Acute postoperative hypertension is a well-known complication of cardiac surgery and is associated with postoperative… 
Highly Cited
2007
Highly Cited
2007
Clevidipine Effectively and Rapidly Controls Blood Pressure Preoperatively in Cardiac Surgery Patients: The Results of the Randomized, Placebo-Controlled Efficacy Study of Clevidipine Assessing Its…
BACKGROUND:Clevidipine is an ultrashort-acting, third-generation IV dihydropyridine calcium channel blocker that exerts rapid and… 
Review
2006
Review
2006
Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control.
Clevidipine is an ultrashort-acting vasoselective calcium antagonist under development for short-term intravenous control of… 
Highly Cited
2006
Highly Cited
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2004
2004
HPLC enantiomer separation of a chiral 1,4-dihydropyridine monocarboxylic acid.
Highly Cited
2002
Highly Cited
2002
Clevidipine in Adult Cardiac Surgical Patients: A Dose-finding Study
Background Treatment of elevated blood pressure is frequently necessary after cardiac surgery to minimize postoperative bleeding… 
Highly Cited
2000
Highly Cited
2000
Pharmacokinetics and Arteriovenous Differences in Clevidipine Concentration following a Short- and a Long-term Intravenous Infusion in Healthy Volunteers
Background: Clevidipine is an ultra–short-acting calcium antagonist developed for reduction and control of blood pressure during… 
Highly Cited
2000
Highly Cited
2000
Coronary and systemic hemodynamic effects of clevidipine, an ultra‐short‐acting calcium antagonist, for treatment of hypertension after coronary artery surgery
Background: The aim was to evaluate the use of clevidipine, a new vascular selective, ultra‐short‐acting calcium antagonist for… 
Highly Cited
1999
Highly Cited
1999
Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers.
AIMS To investigate the tolerability and safety of clevidipine in healthy male volunteers during intravenous infusion at… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)